# Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 Trials

> clinical trial · VERIFIED · 2026-06-25

Status: RECRUITING · Sponsor: UMC Utrecht · Condition: Refractory Epilepsy in Children

- Company: UMC Utrecht
- Sector: neurology
- Primary source: https://clinicaltrials.gov/study/NCT07668856

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.